Published in J Acquir Immune Defic Syndr on August 15, 2003
Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med (2013) 4.26
Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol (2004) 2.94
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol (2008) 2.90
Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann Intern Med (2010) 2.69
Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect (2006) 2.45
Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One (2012) 2.41
Evidence of dysregulation of dendritic cells in primary HIV infection. Blood (2010) 2.39
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis (2011) 2.26
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis (2013) 2.23
The effect of viral suppression on cross-sectional incidence testing in the johns hopkins hospital emergency department. J Acquir Immune Defic Syndr (2008) 1.94
Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward. J HIV AIDS Surveill Epidemiol (2010) 1.90
Designing a genome-based HIV incidence assay with high sensitivity and specificity. AIDS (2011) 1.88
Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol (2005) 1.77
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol (2006) 1.64
Determinants of recent HIV infection among Seattle-area men who have sex with men. Am J Public Health (2008) 1.61
Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS (2008) 1.55
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. J Virol (2007) 1.46
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection. J Acquir Immune Defic Syndr (2009) 1.46
Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil. Transfusion (2011) 1.42
Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009. PLoS One (2010) 1.39
Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection. J Acquir Immune Defic Syndr (2009) 1.34
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PLoS One (2007) 1.30
Using HIV networks to inform real time prevention interventions. PLoS One (2014) 1.29
Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection. J Acquir Immune Defic Syndr (2009) 1.27
Neurocognitive functioning in acute or early HIV infection. J Neurovirol (2010) 1.27
Why the wait? Delayed HIV diagnosis among men who have sex with men. J Urban Health (2010) 1.21
Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. J Clin Microbiol (2005) 1.20
How can we better identify early HIV infections? Curr Opin HIV AIDS (2015) 1.18
Prevalence and correlates of unknown HIV infection among patients seeking care in a public hospital emergency department. Public Health Rep (2009) 1.10
A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals. J Acquir Immune Defic Syndr (2014) 1.05
Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strains. PLoS One (2012) 1.05
Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes. PLoS One (2015) 1.04
High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication. PLoS One (2009) 1.02
Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals. PLoS Pathog (2014) 1.01
APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection. Hum Immunol (2010) 0.92
Developing high-throughput HIV incidence assay with pyrosequencing platform. J Virol (2013) 0.91
The effect of sample handling on cross sectional HIV incidence testing results. PLoS One (2011) 0.90
IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. J Clin Immunol (2010) 0.89
Use of sentinel surveillance and geographic information systems to monitor trends in HIV prevalence, incidence, and related risk behavior among women undergoing syphilis screening in a jail setting. J Urban Health (2008) 0.89
Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants. Retrovirology (2011) 0.89
A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay. J Clin Microbiol (2011) 0.89
Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City. J Acquir Immune Defic Syndr (2012) 0.89
Identifying Recent HIV Infections: From Serological Assays to Genomics. Viruses (2015) 0.88
Evaluation of a multiplex assay for estimation of HIV-1 incidence. PLoS One (2013) 0.87
Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation. PLoS One (2011) 0.83
High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland. AIDS Res Hum Retroviruses (2013) 0.83
HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses. J Virol (2011) 0.82
Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection. BMC Infect Dis (2012) 0.82
Identifying the early post-HIV antibody seroconversion period. J Infect Dis (2011) 0.82
Recent HIV type 1 infection among participants in a same-day mobile testing pilot study in Zimbabwe. AIDS Res Hum Retroviruses (2011) 0.82
Frequency of subtype B and F1 dual infection in HIV-1 positive, Brazilian men who have sex with men. Virol J (2012) 0.81
Inter-laboratory assessment of a prototype multiplex kit for determination of recent HIV-1 infection. PLoS One (2013) 0.81
The potential role of biomarkers in HIV preventive vaccine trials. J Acquir Immune Defic Syndr (2009) 0.81
Personal and contextual factors related to delayed HIV diagnosis among men who have sex with men. AIDS Educ Prev (2014) 0.81
Dynamics of HIV type 1 recombination following superinfection. AIDS Res Hum Retroviruses (2013) 0.80
Partner services in adults with acute and early HIV infection, San Diego, 1996-2014. AIDS (2016) 0.80
Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis. Sci Rep (2016) 0.78
Current and future assays for identifying recent HIV infections at the population level. Med Sci Monit (2011) 0.78
Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort. PLoS One (2016) 0.77
Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection. PLoS One (2013) 0.77
Drug resistant HIV: Behaviors and characteristics among Los Angeles men who have sex with men with new HIV diagnosis. PLoS One (2017) 0.75
A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection. PLoS One (2015) 0.75
The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards. Sci Rep (2017) 0.75
Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014. BMC Infect Dis (2017) 0.75
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep (2006) 37.28
Estimation of HIV incidence in the United States. JAMA (2008) 21.27
Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr (2005) 15.14
Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab (2002) 13.06
Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS (2006) 11.20
Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect (2005) 8.62
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep (2006) 5.63
Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect (2004) 5.32
Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect (2005) 4.93
A simple and improved correction for population stratification in case-control studies. Am J Hum Genet (2007) 4.29
Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS (2004) 4.17
Inference on haplotype effects in case-control studies using unphased genotype data. Am J Hum Genet (2003) 3.74
Unrecognized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men: opportunities for advancing HIV prevention in the third decade of HIV/AIDS. J Acquir Immune Defic Syndr (2005) 3.56
Racial/ethnic and age disparities in HIV prevalence and disease progression among men who have sex with men in the United States. Am J Public Health (2007) 3.50
Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Perspect (2006) 3.49
Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr (2005) 3.25
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21
Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. Environ Health Perspect (2004) 2.96
Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). Environ Sci Technol (2007) 2.88
Marginal analyses of clustered data when cluster size is informative. Biometrics (2003) 2.74
Informative missingness in genetic association studies: case-parent designs. Am J Hum Genet (2003) 2.66
Age-associated DNA methylation in pediatric populations. Genome Res (2012) 2.53
Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet (2002) 2.50
Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genet Med (2011) 2.41
Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr (2006) 2.36
Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr (2003) 2.21
Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr (2002) 2.08
Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach. PLoS One (2007) 2.08
Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem (2010) 2.07
Genetic association analysis using data from triads and unrelated subjects. Am J Hum Genet (2005) 2.06
Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand. AIDS Res Hum Retroviruses (2003) 2.04
Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis (2005) 2.03
Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ Sci Technol (2006) 1.98
Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem (2007) 1.88
Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004. J Expo Sci Environ Epidemiol (2008) 1.84
Levels in the U.S. population of those persistent organic pollutants (2003-2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements. Environ Sci Technol (2009) 1.77
Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population. Environ Res (2008) 1.76
Repeat HIV testing, risk behaviors, and HIV seroconversion among young men who have sex with men: a call to monitor and improve the practice of prevention. J Acquir Immune Defic Syndr (2002) 1.72
A signed-rank test for clustered data. Biometrics (2007) 1.72
Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders. Clin Chem (2008) 1.71
HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. AIDS Res Hum Retroviruses (2003) 1.68
Total blood mercury concentrations in the U.S. population: 1999-2006. Int J Hyg Environ Health (2009) 1.66
Concentrations of environmental chemicals associated with neurodevelopmental effects in U.S. population. Neurotoxicology (2005) 1.60
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Recent HIV testing among young men who have sex with men: correlates, contexts, and HIV seroconversion. Sex Transm Dis (2006) 1.49
Polyfluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001-2002. Environ Sci Technol (2009) 1.48
Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health (2010) 1.45
Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr (2005) 1.44
Report from a workshop on multianalyte microsphere assays. Cytometry (2002) 1.43
Investigating childhood leukemia in Churchill County, Nevada. Environ Health Perspect (2007) 1.40
Epidemiology of HIV in the United States and Canada: current status and ongoing challenges. J Acquir Immune Defic Syndr (2009) 1.37
HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. J Acquir Immune Defic Syndr (2002) 1.37
Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol (2002) 1.37
Total TEQ reference range (PCDDs, PCDFs, cPCBs, mono-PCBs) for the US population 2001-2002. Chemosphere (2008) 1.36
Variability among five over-the-counter blood glucose monitors. Clin Chim Acta (2005) 1.33
MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasive Streptococcus pyogenes isolates. FEMS Immunol Med Microbiol (2008) 1.31
Statistical models for haplotype sharing in case-parent trio data. Hum Hered (2007) 1.26
A permutation procedure to correct for confounders in case-control studies, including tests of rare variation. Am J Hum Genet (2012) 1.25
Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the Centers for Disease Control and Prevention. Semin Perinatol (2010) 1.21
Inference on haplotype/disease association using parent-affected-child data: the projection conditional on parental haplotypes method. Genet Epidemiol (2007) 1.18
Public goods, private data: HIV and the history, ethics, and uses of identifiable public health information. Public Health Rep (2007) 1.16
Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya. J Infect Dis (2003) 1.15
Late preterm birth and risk of developing asthma. J Pediatr (2010) 1.13
Polybrominated diphenyl ethers, polychlorinated biphenyls, and persistent pesticides in serum from the national health and nutrition examination survey: 2003-2008. Environ Sci Technol (2013) 1.12
Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. Clin Chim Acta (2010) 1.11
Effect of population stratification on the identification of significant single-nucleotide polymorphisms in genome-wide association studies. BMC Proc (2009) 1.11
National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev (2006) 1.10
A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease. Genet Epidemiol (2009) 1.10
Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen. J Med Screen (2006) 1.07
Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters. Clin Chim Acta (2009) 1.05
Progress toward implementation of integrated systems for surveillance of HIV infection and morbidity in the United States. Public Health Rep (2007) 1.01
Efficacy of a booster counseling session 6 months after HIV testing and counseling: a randomized, controlled trial (RESPECT-2). Sex Transm Dis (2005) 0.99
Pharmacokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Seveso adults and veterans of operation Ranch Hand. J Expo Anal Environ Epidemiol (2002) 0.97
Reference range levels of polycyclic aromatic hydrocarbons in the US population by measurement of urinary monohydroxy metabolites. Environ Res (2005) 0.96
Random error and undercounting in birth defects surveillance data: implications for inference. Birth Defects Res A Clin Mol Teratol (2003) 0.95
Advancing HIV prevention demonstration projects: new strategies for a changing epidemic. Public Health Rep (2009) 0.95
Levels of 1-hydroxypyrene and other monohydroxy polycyclic aromatic hydrocarbons in children: a study based on U.S. reference range values. Toxicol Lett (2006) 0.94
Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population. Clin Chem (2011) 0.94
Genetic studies of a cluster of acute lymphoblastic leukemia cases in Churchill County, Nevada. Environ Health Perspect (2007) 0.94
Preliminary proficiency testing results for succinylacetone in dried blood spots for newborn screening for tyrosinemia type I. Clin Chem (2009) 0.93
Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM). Clin Chim Acta (2010) 0.92
Newborn Screening System Performance Evaluation Assessment Scheme (PEAS). Semin Perinatol (2010) 0.92
HFE genotype and transferrin saturation in the United States. Genet Med (2003) 0.91
Naming and counting disorders (conditions) included in newborn screening panels. Pediatrics (2006) 0.91
Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials. Clin Chem (2003) 0.91
Robust estimation and testing of haplotype effects in case-control studies. Genet Epidemiol (2008) 0.91
Quantification of malonylcarnitine in dried blood spots by use of MS/MS varies by stable isotope internal standard composition. Clin Chim Acta (2008) 0.90
Detection of TPN contamination of dried blood spots used in newborn and metabolic screening and its impact on quantitative measurement of amino acids. Clin Chim Acta (2011) 0.90
Control for confounding in case-control studies using the stratification score, a retrospective balancing score. Am J Epidemiol (2011) 0.89
Proficiency testing of human leukocyte antigen-DR and human leukocyte antigen-DQ genetic risk assessment for type 1 diabetes using dried blood spots. J Diabetes Sci Technol (2010) 0.89
HIV seroconverting donors delay their return: screening test implications. Transfusion (2002) 0.88
Maternal smokeless tobacco use in Alaska Native women and singleton infant birth size. Acta Obstet Gynecol Scand (2011) 0.88
Classification of transmission risk in the national HIV/AIDS surveillance system. Public Health Rep (2003) 0.88
Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol (2003) 0.88